Search results
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Reuters via Yahoo Finance· 2 hours ago(Reuters) -GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing...
Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for
Zacks via Yahoo Finance· 1 day agoPfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings...
Pfizer Shareholders Reject Political Spending, Lobbying Proposal
Bloomberg Law· 2 hours agoPfizer investors dismissed a proposal that would have required the drugmaker to disclose how its political donations square with its publicly stated values, at the company ...
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
KFGO· 2 days agoBy Sam Tobin LONDON (Reuters) - Pfizer and BioNTech asked a London court to revoke rival Moderna's...
Pfizer and Levi Strauss Face Challenges from Conservative Shareholders Over Support of Divisive...
National Center for Public Policy Research· 1 day agoWashington, D.C. – At this week’s Pfizer and Levi Strauss annual shareholder meetings, shareholder...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 21 hours agoPfizer stock is trading near an 11-year low as the drugmaker looks for its next big break after...
Better Buy: Pfizer vs. Viking Therapeutics
Motley Fool via Yahoo Finance· 2 days agoAt the same time, several big pharma companies continue to offer attractive valuations and dividend yields. Image Source: Getty Images. Pfizer (NYSE:...
Sigma Planning Corp Lowers Stake in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 3 days agoSigma Planning Corp lowered its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 52.6% in the fourth quarter, according to its most recent 13F filing with the SEC ...
Pfizer Inc. (PFE) Becoming More Attractive for Investors – Knox Daily
Knox Daily· 3 days agoPfizer Inc.’s recent filing unveils that its Director Gottlieb Scott acquired Company’s shares for reported $79401.0 on Dec 15 ’23. In the deal valued at $26.47 per share, ...
EU regulators approve Pfizer antibiotic Emblaveo (NYSE:PFE)
Seeking Alpha· 3 days agoEU regulators have approved Pfizer (PFE) and AbbVie’s (ABBV) antibiotic product Emblaveo for the...